Beena Thannickal
| This email address is being protected from spambots. You need JavaScript enabled to view it.
A new eight-week FreshStart! program beginning Feb. 1 will help cancer survivors make healthy lifestyle changes.
Proceeds from the annual ArtBLINK Gala support high-priority and life-saving research.
UAB Comprehensive Cancer Center’s Patient Care Connect Program received a distinguished Innovator Award from the Association of Community Cancer Centers for providing stellar cancer care with cost savings.
A UAB researcher has received a 2017 Susan G. Komen grant to investigate combination drug therapies for HER2-positive breast cancer.
UAB is the first in the country to use novel HyperArc High-Definition Radiotherapy on brain cancer patients.
UAB Hospital has received a 2017 Women’s Choice Award for being one of America’s Best Breast Centers in the United States.
Several activities are planned in and around UAB for Breast Cancer Awareness Month.
An art event will be held Aug. 17 to engage the cancer community in the healing power of art.
UAB is the only institution in Alabama chosen to date to participate in the TAPUR Study to help further understand targeted therapies in patients with advanced cancers.
Recent findings from an innovative nationwide trial indicate that the drug pembrolizumab, when used in combination with standard therapy, may provide positive results for patients with locally advanced breast cancer.